Psychiatric Services
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Psychiatr Serv 57:123-126, January 2006
doi: 10.1176/appi.ps.57.1.123
© 2006 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Kilbourne, A. M.
* Articles by Pincus, H. A.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Kilbourne, A. M.
* Articles by Pincus, H. A.
Related Collections
* Veterans
* Bipolar Disorder

Brief Report

Brief Reports: Patterns of Psychotropic Medication Use by Race Among Veterans With Bipolar Disorder

Amy M. Kilbourne, Ph.D., M.P.H. and Harold Alan Pincus, M.D.

OBJECTIVE: This study investigated whether race was associated with patterns of psychotropic medication use among veterans with bipolar disorder. METHODS: Data were examined for veterans from the mid-Atlantic region with a diagnosis of bipolar disorder in fiscal year 2001. Prescription data determined whether differences existed between black and nonblack patients in the receipt of lithium, other mood stabilizers, all mood stabilizers, first-generation antipsychotics, second-generation antipsychotics, all antipsychotics, selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants, all antidepressants, and benzodiaze-pines. RESULTS: Data for 2,958 patients were sampled: 347 blacks and 2,611 nonblacks. Multivariable analyses that adjusted for patient and clinical factors revealed that compared with nonblacks, blacks were significantly less likely to receive lithium and SSRIs and significantly more likely to receive first-generation antipsychotics and any antipsychotic. CONCLUSIONS: These findings suggest that efforts should be made to reduce disparities in access to pharmacotherapy among patients with bipolar disorder.




This article has been cited by other articles:


Home page
The Annals of PharmacotherapyHome page
M. Yang, J. C Barner, K. A Lawson, K. L Rascati, J. P Wilson, M L. Crismon, J. Worchel, and C. A Mascarenas
Antipsychotic Medication Utilization Trends Among Texas Veterans: 1997-2002
Ann. Pharmacother., September 1, 2008; 42(9): 1229 - 1238.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2006 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org